Trial | NCT01496053  Report issue

Title

Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD)
Anti-inflammatory Effect of a Mushroom Extract (AndoSan)in Patients With Inflammatory Bowel Disease. A Prospective Study

  • Phase

    Phase 2/Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    100
Examine whether daily oral ingestion of a immunomodulatory mushroom extract (AndoSanTM) in patients with ulcerative colitis (UC) and Crohn's disease (CD), experience clinical, biochemical and genetical improvement in their disease.

A prospective randomised study comparing the mushroom extract with placebo.
Study Started
Dec 31
2011
Primary Completion
Dec 31
2015
Study Completion
Jan 31
2016
Last Update
Oct 08
2020

Dietary Supplement AndoSan

AndoSan 30 ml x 2 for 21 days

Dietary Supplement Sugar Extract

Sham comparator

AndoSan Active Comparator

AndoSan given to IBD patients

Sugar extract Sham Comparator

Sugar extract to IBD patients

Criteria 

Inclusion Criteria:

moderate disease

Exclusion Criteria:

serious disease,
biological treatment,
pregnancy.
No Results Posted